Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 14thApril 2025 Vol. No. 14 ; Issue No.678
Publications

1. Mahaddalkar T, Banerjee A, Ketkar M, Thorat R, Gardi N, Dutt S (2025). Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence. Oncogene.

2. More A, Parikh P, Kamtalwar S, Pagdhune A (2025). A case series of Pseudohyperkalemia: A diagnostic dilemma in cancer patients with reactive thrombocytosis. Cureus. 17(4):e81851

3. Dholam KP, Somani P, Gurav S, Dugad J, Kharade P, Rane PP, Singh GP (2025). Longitudinal assessment of trismus in patients with advanced stage oral and oropharyngeal cancer. Journal of Prosthetic Dentistry.

4. Mukhare R, Gandhi KA, Kadam A, Raja A, Singh A, Madhav M, Chaubal R, Pandey S, Gupta S (2025). Integration of organoids with CRISPR screens: A narrative review. Biology of the Cell. 117(4):e70006.

5. Saravanan L, Mahale A, Gota V, Khandelia P, Kulkarni OP (2025). Necrostatin-1 attenuates oral squamous cell carcinoma by modulating tumour immune response in mice. Fundamental and Clinical Pharmacology. 39(3):e70008.

6. Sandhbor P, John G, Bhat S, Goda JS (2025). Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases. Asian Journal of Pharmaceutical Sciences. 20(2):101021.

Site of the Week

plprot is a plastid protein database which integrates data from large scale proteome analyses of different plastid types.These include etioplasts, chloroplasts, chromoplasts and the undifferentiated proplastid-like organelles of tobacco BY2 cells.

desktop Image
Interesting Reads

Linderman SW, DeRidder L, Sanjurjo L, Foote MB, Alonso MJ, Kirtane AR, Langer R, Traverso G (2025). Enhancing immunotherapy with tumour-responsive nanomaterials. Nature Reviews Clinical Oncology. 22(4):262-282.

Video of the Week
Management of Classical Hodgkin lymphoma
Upcoming Events
6th International Cancer Research and Drug Discovery Conference (i-Cancer Congress)

May 26-27, 2025

At Toronto, Canada

Tobacco Control & Cessation

May 20-21, 2025

At Tata Memorial Hospital, Parel, Mumbai.

Workshop on Clinical Research Methods and Protocol Development- AAZPIRE 2025

May 15-18, 2025

At ACTREC, Tata Memorial Centre, Kharghar , Navi Mumbai
Do You Know?

In 2016, Atezolizumab, the first of an emerging class of inhibitors of PD-L1, was approved by the FDA for the treatment of urothelial carcinoma.

 back Image
Cancer News
Immune reactivating antibody therapy shows promise against ovarian cancer in new study.

MedicalXpress, 10/04/2025

The research showed that MOv18 IgE works in a unique way, by reversing the suppression of the immune system imposed by the tumor, through activation of different groups of immune cells against the cancer...

Brain pathway links inflammation to loss of motivation, energy in advanced cancer.

EurekAlert, 10/04/2025

Scientists discovered that a structure in the brainstem, a part of the brain that controls vital functions such as breathing and heart rate, acts as a sensor for inflammatory signals in the bloodstream, particularly a molecule called interleukin-6 (IL-6), which is elevated in cancer cachexia...

Lab grown lung cancer cells show potential to revolutionise treatment

PharmaTimes, 10/04/2025

Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma (LUSC), a type of lung cancer, which has the potential to develop more effective treatments for the disease as well as other cancers...

2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)